About Agio Pharmaceuticals Limited
Data last updated: 01 January 2026
Agio Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 January 1992, the company has been in operation for over 34 years.
Registered with ROC Mumbai under CIN U24239MH1992PTC065031.
Capital: an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.18 Cr. It is led by directors including Mahendra Kumar Kumawat and Raghav Sanjay Ruia.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 38 Nandjyot Industrial Estate Kurla Andheri Road Safed Pool, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2025, the company reported a revenue of ₹287.95 Cr, a growth of 29% compared to the previous year.
The company has a workforce of approximately 343 employees as per the latest available data.
The company is associated with 1 brand - Agio Pharmaceuticals. As per MCA filings, the company has open charges of ₹75.02 Cr and satisfied charges of ₹205.08 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agio-pharma.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressA – 38 Nandjyot Industrial Estate Kurla Andheri Road Safed Pool, Mumbai, Maharashtra, India – 400072
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): U24239MH1992PTC065031. The current CIN is U24239MH1992PLC065031, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1992PLC065031 | Current |
| U24239MH1992PTC065031 | Previous |
Associated Brands with Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited operates one associated brand: Agio Pharmaceuticals. These brands represent Agio Pharmaceuticals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products for human and animal healthcare operations in India. | agio-pharma.com |
Business Activity of Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Agio Pharmaceuticals Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahendra Kumar Kumawat | Whole-Time Director | 09 Sep 2020 | 5 Years 11 Months | Current |
|
Raghav Sanjay Ruia
Also directs:
Bhakti Enterprises Limited
|
Whole-Time Director | 04 Oct 2019 | 6 Years 10 Months | Current |
| Madhusudan Govindprasad Ruia | Managing Director | 24 Jan 1992 | 34 Years 6 Months | Current |
Financials of Agio Pharmaceuticals Limited FY 2025 filings available
Agio Pharmaceuticals Limited reported revenue of ₹287.95 Cr (up 29.00% YoY) for FY 2025.
Ten-year financial statements for Agio Pharmaceuticals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Agio Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Hdfc Bank Limited | ₹43 Lakh | Open |
| 28 Nov 2024 | Others | ₹58 Lakh | Open |
| 18 Mar 2024 | Sbicap Trustee Company Limited | ₹65.69 Cr | Open |
| 10 Nov 2023 | Others | ₹51 Lakh | Open |
| 21 Jul 2023 | Axis Bank Limited | ₹80 Lakh | Open |
Total charge records: 25 View all charges
Employees and EPFO Compliance at Agio Pharmaceuticals Limited
View historical data on people associated with Agio Pharmaceuticals Limited, including employment history and EPFO contributions.
Employee and EPFO history for Agio Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Agio Pharmaceuticals Limited
GST registrations and filing compliance for Agio Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Agio Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Agio Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Agio Pharmaceuticals Limited
MSME payment history for Agio Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Agio Pharmaceuticals Limited
Corporate group structure for Agio Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Agio Pharmaceuticals Limited
MCA filings and documents for Agio Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Agio Pharmaceuticals Limited
Frequently Asked Questions about Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 24 January 1992 (34+ years old) and is registered under CIN U24239MH1992PLC065031. The company has 343 employees.
Agio Pharmaceuticals Limited reported revenue of ₹287.95 Cr for FY 2025 (up 29.00% YoY).
The current directors of Agio Pharmaceuticals Limited are:
- Mahendra Kumar Kumawat - Whole-Time Director
- Raghav Sanjay Ruia - Whole-Time Director
- Madhusudan Govindprasad Ruia - Managing Director
The primary industry of Agio Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Agio Pharmaceuticals Limited can be reached at the registered office: A – 38 Nandjyot Industrial Estate Kurla Andheri Road Safed Pool, Mumbai, Maharashtra, India – 400072, or through the website agio-pharma.com.
The authorised capital is ₹6 Cr, and the paid-up capital is ₹5.18 Cr.